about
Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies.S. mansoni Trapping in Lungs Contributes to Resistance to ReinfectionNovel therapeutic and prevention approaches for schistosomiasis: reviewSchistosomiasis vaccines: where do we stand?Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticityExperiences and perspectives of community health workers from implementing treatment for schistosomiasis using the community directed intervention strategy in an informal settlement in Kisumu City, western Kenya.Development of a Streptococcus gordonii vaccine strain expressing Schistosoma japonicum Sj-F1 and evaluation of using this strain for intranasal immunization in mice.Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni.Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.Expression and immune characterization of a novel enzyme, protein arginine methyltransferase 1, from Schistosoma japonicumIt's All about Those Bases: The Need for Incorporating Parasite Genetic Heterogeneity into the Development of Schistosome VaccinesDistribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica.In Vivo MRI Assessment of Hepatic and Splenic Disease in a Murine Model of Schistosomiasis [corrected].Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.What is required in terms of mass drug administration to interrupt the transmission of schistosome parasites in regions of endemic infection?Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni.Natural products as a source for treating neglected parasitic diseases.Development of a schistosomiasis vaccine.Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.Vaccines and diagnostics for zoonotic schistosomiasis japonica.Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials.Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice.A Rare Case of Schistosomiasis (Bilharzia) of the Bladder in a Non-Endemic AreaVaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.Ellagic acid reduces murine schistosomiasis mansoni immunopathology via up-regulation of IL-10 and down-modulation of pro-inflammatory cytokines production.Distribution of lethal giant larvae (Lgl) protein in the tegument and negative impact of siRNA-based gene silencing on worm surface structure and egg hatching in Schistosoma japonicum.Pharmacokinetics and risk evaluation of DNA vaccine against Schistosoma japonicum.Analysis of the interactome of Schistosoma mansoni histone deacetylase 8.Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni.
P2860
Q26765026-952D162B-2F1F-480E-B613-999F1C845893Q26830904-26DC2A3D-5E43-4DDB-9D68-179C0EDA1685Q27008897-655D2E38-F94F-42D0-9D1D-EDE4CCF1975AQ28066042-653744AD-766B-426F-BBF3-45E53170916DQ28081158-E7234558-186A-41B8-BFBB-ED4D4813E3F6Q28538911-9BF16AD3-933F-4323-8693-F057960B40F1Q30812014-B18AC3B4-7480-46DB-9CF8-736A61BE2E36Q31110824-D24B1F0D-ECDC-4D19-9B74-7FE8E27B3BB1Q33684408-70D11435-8ACB-423F-AAEF-AF3A3107E959Q34033792-28368F3C-6C21-4764-AD77-5FF56E514DE8Q34297640-2331D43D-7FE7-4C0B-909F-C45D11EF7F2DQ35068709-A921AB2A-9ED2-4AC0-8ECD-01E108A5FB93Q35667056-87522EA9-2F30-4455-99C1-22413AE31B1DQ35748586-0EB86376-BC9E-4E1C-ABBA-17686D6C7F83Q35783774-2F1E5CF9-9BD9-4A36-AD37-5B7274660C42Q35826651-97DDBB0B-A768-4FEB-875C-76B11BD0067EQ36201906-D1A11F2F-73AA-4F8A-B4DF-592277C74C2AQ36368518-A21BA1EB-F08B-4C55-8E22-C477C5215497Q36656087-017AA08F-18D6-4320-AE05-F0195CCF04BAQ37350747-9A268701-3645-477B-B8EC-B961EA6C3817Q37603033-CEB02B33-77C7-46AB-A8D4-4915BCB29F8CQ38264085-FACFA283-7101-41FE-AF9D-1382CC584E3DQ39014289-B8C1E0B6-56D1-41FC-833C-3C71AB6F1D89Q39164396-3DE6F393-B934-45E6-8061-5AD97CDA296EQ39523469-2A153FA8-750A-4DA0-8095-4C577CD13E70Q39551535-157A5C5E-2E99-4404-B2CD-E8B515ACDACFQ40653441-31531F04-45F1-49B1-BF65-AFC71B9EDBBDQ42445994-626AAE40-6D50-4307-A805-FBEBE79EF95BQ44604745-44F98F51-E0FE-417C-82E5-4A06E0245C86Q47384586-6D2D1C9D-576D-404A-AC5C-CAE9C2F76FA1Q48237579-74325494-7E48-46C8-AAE9-B05018726044
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Schistosomiasis vaccines
@ast
Schistosomiasis vaccines
@en
Schistosomiasis vaccines
@nl
type
label
Schistosomiasis vaccines
@ast
Schistosomiasis vaccines
@en
Schistosomiasis vaccines
@nl
prefLabel
Schistosomiasis vaccines
@ast
Schistosomiasis vaccines
@en
Schistosomiasis vaccines
@nl
P2093
P2860
P3181
P356
P1433
P1476
Schistosomiasis vaccines
@en
P2093
Afzal A Siddiqui
Bilal A Siddiqui
Lisa Ganley-Leal
P2860
P304
P3181
P356
10.4161/HV.7.11.17017
P407
P5008
P577
2011-11-01T00:00:00Z